Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421606 | SCV000536406 | uncertain significance | not provided | 2022-06-03 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
New York Genome Center | RCV001782906 | SCV002025667 | uncertain significance | Developmental delay with autism spectrum disorder and gait instability | 2020-04-28 | criteria provided, single submitter | clinical testing | The inherited p.Arg3906Cys in the HERC2 gene has not been reported in the literature in individuals with neurological disorders. The variant has 0.00006771 allele frequency (17 out of 251,080 heterozygous alleles) in the gnomAD database indicating it is a rare allele in the general population. The variant affects moderately conserved residues. In silico prediction tools provide conflicting interpretations about the variants potential deleterious effects on normal protein function. Based on the available evidence, the inherited p.Arg3906Cys varaint in the HERC2 gene is assessed as a variant of uncertain significance. |
Labcorp Genetics |
RCV000421606 | SCV004272592 | uncertain significance | not provided | 2024-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 3906 of the HERC2 protein (p.Arg3906Cys). This variant is present in population databases (rs770688775, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with HERC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 393051). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt HERC2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |